Capula Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,500
Closed -$217K 967
2026
Q1
$217K Buy
2,500
+800
+47% +$76.6K ﹤0.01% 721
2025
Q4
$163K Sell
1,700
-400
-19% -$38.9K ﹤0.01% 633
2025
Q3
$200K Buy
2,100
+700
+50% +$64.3K ﹤0.01% 612
2025
Q2
$122K Buy
+1,400
New +$119K ﹤0.01% 473
2024
Q4
Sell
-2,200
Closed -$198K 511
2024
Q3
$198K Buy
+2,200
New +$185K ﹤0.01% 378
2023
Q3
Sell
-29,300
Closed -$2.58M 604
2023
Q2
$2.58M Sell
29,300
-36,000
-55% -$3.1M 0.06% 128
2023
Q1
$5.26M Sell
65,300
-51,400
-44% -$4.19M 0.06% 233
2022
Q4
$9.07M Sell
116,700
-312,000
-73% -$25.3M 0.12% 193
2022
Q3
$34.6M Buy
428,700
+320,700
+297% +$28.8M 0.47% 45
2022
Q2
$9.69M Buy
+108,000
New +$10.9M 0.17% 147
2020
Q3
Sell
-10,500
Closed -$963K 255
2020
Q2
$963K Sell
10,500
-36,400
-78% -$3.49M 0.03% 251
2020
Q1
$4.23M Buy
+46,900
New +$4.99M 0.15% 172

Other funds holding MDT

Capula Management's MDT Position: Q2 2026 in Review

Capula Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 6,991 shares — an estimated $606K sold.

Capula Management first reported a position in MDT in Q1 2020 and held it in 14 quarters. The position peaked at $7.14M in Q3 2022. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Capula Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 6,991 Medtronic shares in Q2 2026, an estimated $606K.
  • Capula Management first reported a position in Medtronic in Q1 2020 and held it in 14 quarters.
  • Capula Management's Medtronic position peaked at $7.14M in Q3 2022.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.